基于原酶透的纳米医学,用于由低剂量化疗诱导的瘤免疫疗法
Jinxiang Liu1, Longqing Si1, Song Li1
1School of Pharmacy, Binzhou Medical University, Yantai, 264003, China.
Materials today. Bio
|March 5, 2026
概括
这项研究开发了基于原酶-IV (COL) 的纳米粒子,以增强化学疗法的深度瘤透. 这种由酶增强的策略可以改善药物输送,并增强抗瘤免疫反应,以有效治疗癌症.
科学领域:
- 生物医学工程 生物医学工程
- 纳米医学是一种纳米医学.
- 癌症治疗 癌症治疗
背景情况:
- 瘤微环境 (TME) 挑战了纳米粒子向固体瘤的传递.
- 密集的细胞外基质 (ECM) 和不良的血管系统限制了药物透到深层瘤区域.
研究的目的:
- 开发一种基于原酶-IV (COL) 的纳米药物,用于增强深度瘤透.
- 将化疗与免疫疗法结合起来,以获得协同作用的抗瘤效应.
主要方法:
- 将原酶-IV (COL) 和多塞 (DTX) 联合封装成牛血清白蛋白 (BSA) 纳米颗粒 (COL/DTX@BSA NPs).
- 使用COL作为"分子剪刀"来降解ECM并改善纳米粒子和药物透.
- 研究DTX诱导的免疫细胞死亡 (ICD) 和抗瘤免疫反应.
主要成果:
- COL显著增强了纳米粒子和DTX的深度瘤透.
- DTX诱导了ICD,释放了与损伤相关的分子模式并激活了抗瘤免疫力.
- 通过COL介导的透使低剂量的DTX能够在深层瘤中有效诱导ICD,显示出协同化学免疫疗法.
结论:
- 基于COL的纳米医学提供了一种针对深层瘤的新策略.
- 酶增强透与化疗免疫疗法相结合,有望改善癌症治疗.
- 这种方法扩大了低剂量化疗诱导的ICD在纳米医学中的应用.
相关概念视频
02:17The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K